WW International

Name

WW International

Legal name

WW International, Inc.

Website

https://corporate.ww.com

Company type

Public

Founded year

1963

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Weight Management Services

NAICS

Diet and Weight Reducing Centers (812191)

SIC

Services-Home Health Care Services (8082)

akta.pro primary industry

Obesity Medicine & Weight Management (HLAKADAL)

akta.pro secondary industries

Weight Loss Coaching (Non-Clinical) (HSADAFAB), Weight Management & Behavior Change Education (EDAAAHAF), Corporate/Workplace Nutrition & Weight Management Programs (HSADAFAO)

Keywords

• Weight management services
• Behavioral health subscriptions
• Clinical weight programs
• Digital wellness platform
• GLP-1 medication support

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B and B2C

Offering type

Services

Revenue model

1. Behavioral Subscription Revenue: Fees from digital product subscriptions with optional unlimited workshop access. Core subscription tiers include Core+, a higher-value behavioral tier with expert support and community experiences.
2. Clinical Subscription Revenue: Fees from clinical product offerings provided by Weight Watchers Clinic combined with digital subscription products and unlimited workshop access. Includes access to GLP-1 medications when clinically appropriate.
3. Other Revenue: Revenue from licensing, franchise fees with respect to commitment plans and royalties, publishing and other revenue sources.

Pricing tiers

Go-to-market motion2 records

Distribution channels7 records

Marketing channels5 records

Core offering

WW International (operating as Weight Watchers) sells subscription-based weight management programs combining behavioral coaching, nutrition tracking, and community support with clinical interventions and access to GLP-1 medications when clinically appropriate. Offerings include digital subscriptions (with optional in-person workshops), clinical subscriptions via Weight Watchers Clinic, premium tiers (Core+, Med+), and an enterprise platform (Weight Watchers for Business) for employers, health plans, and payers.

Product overview

WW International operates as a science-backed weight management company with a multi-tiered platform architecture. The core offering consists of Behavioral Subscriptions (digital product with optional workshop access) and Clinical Subscriptions (combining Weight Watchers Clinic offerings with digital products and workshops). The Med+ Program serves as the company's flagship clinical tier, combining GLP-1 medication access with behavioral support. Higher-value tiers include Core+ (premium behavioral tier with expert support and community) and the GLP-1 Success Program for medication users. The ecosystem includes add-on features like the AI Body Scanner, Weight Health Score, PVOLVE strength workouts, Menopause Program, and RxFlexFund employer subsidy. The company also offers Weight Watchers for Business, a B2B platform for employers, health plans, and payers.

Differentiator

Problem solved

Functional benefit

Brands

• Weight Watchers Clinic: Clinical weight management program providing access to GLP-1 medications and medical supervision
• Med+
• Core+
• GLP-1 Companion Programme
• Weight Watchers for Business

Products and services

• Med+ Program

Quantifiable outcome

• Members prescribed GLP-1 medications who engaged with behavioral support lost 61.3% more weight at one month compared to medication-only users
• +5 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Nine partnerships are on record, tiered minor and core.

• American Heart AssociationminorStrategic or Co-development Partner · 22 June 2026Continued partnership supporting the Healthy Living BEYOND Weight Study, a nationwide research initiative examining real-world health experiences of adults managing weight through various treatment pathways including GLP-1s, surgery, and lifestyle approaches.
• CheqUpcoreStrategic or Co-development Partner · 16 June 2026Two-way partnership allowing Weight Watchers UK members to access CheqUp's medical weight loss programme and CheqUp members to use the Weight Watchers app and GLP-1 Companion Programme. Builds on initial 2025 collaboration and aligns with NHS expansion of GLP-1 medication access.
• Eli Lilly (LillyDirect)coreStrategic or Co-development Partner · 4 June 2026Weight Watchers Med+ program combining GLP-1 medication access with clinical and behavioral support is now accessible through Eli Lilly's digital healthcare platform LillyDirect, enabling patients to connect with independent care options and pharmacy fulfillment resources.
• Farmer's FridgeminorGTM or Marketing Partner · 1 March 2026National Nutrition Month partnership featuring six Weight Watchers-curated menu items across Farmer's Fridge's network of 1,800+ smart refrigerators in airports, hospitals, offices, and universities. Includes 50% off first purchase promotion for new customers.
• PVOLVEminorStrategic or Co-development Partner · 10 February 2026Strategic partnership integrating clinically validated strength training into Weight Watchers programs. Members receive exclusive PVOLVE classes, access to 1,700+ on-demand workouts, and curated resistance equipment at member rates. Supports muscle preservation during GLP-1 medication use.
• Amazon PharmacycoreStrategic or Co-development Partner · 16 December 2025Partnership for medication delivery enabling easier and faster access to weight loss medications for Weight Watchers members through Amazon Pharmacy.
• Novo NordiskcoreStrategic or Co-development Partner · 12 November 2025Plans to offer Novo Nordisk's Wegovy pill after 2026 US launch, enhancing obesity treatment offerings. Collaboration aligns with Weight Watchers' strategy to support branded obesity drugs and attract more customers amid competitive GLP-1 market.
• Amazon PharmacycoreChannel Partner/ Reseller/ Distributor · 20 October 2025Collaboration agreement to distribute weight management medications making it easier for customers to access weight loss products through Amazon Pharmacy integration.
• Sequence (Acquired)coreStrategic or Co-development Partner · 6 March 2023Acquired digital health platform Sequence for $100 million to help customers access GLP-1 medications. The acquisition provides telemedicine capabilities and expands Weight Watchers' clinical weight management services.

Scale indicators14 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Ro: Ro operates the leading direct-to-patient telehealth platform for weight loss, including GLP-1 prescription via its 'Ro Body' program — directly competing with WW Med+ for the same GLP-1 patient population.
• Noom: Noom is a direct competitor in digital subscription weight management, offering app-based behavioral coaching, psychology-based programs, and increasingly bundled GLP-1 support — overlapping directly with WW's behavioral subscription and emerging clinical offerings.
• Nutrisystem: Nutrisystem is a long-standing direct competitor in commercial weight management with a meal-delivery plus coaching subscription model — comparable to WW's legacy behavioral and Points-based offerings.
• Calibrate: Calibrate is a direct competitor offering a metabolic reset program combining clinician-prescribed GLP-1 medication with one-on-one coaching — a near-identical value proposition to WW Med+ targeting the same patient segment.
• Mayo Clinic Diet: Mayo Clinic Diet is a direct competitor offering a clinically-branded weight management program with meal planning, behavior change, and an emerging digital subscription — comparable in brand-led weight management positioning.
• Found (Found Health): Found is a direct competitor offering clinician-supervised weight loss programs with optional GLP-1 prescribing — competing head-on with WW Med+ and Weight Watchers Clinic.
• Jenny Craig: Jenny Craig is a historical direct competitor in commercial weight loss with structured food, coaching, and counseling — a parallel membership-style model to WW workshops. Also previously went through bankruptcy, illustrating category dynamics.
• Hims & Hers Health: Hims & Hers Health is a direct competitor in telehealth weight loss with bundled GLP-1 access, subscription pricing, and direct-to-consumer distribution — competing for the same Med+ customer profile.

Emerging players

• Virta Health: Virta Health is an emerging player in metabolic health and type-2 diabetes reversal with clinically validated outcomes — a partial peer that overlaps with WW's clinical positioning and payor/employer contracting motion.

Broad incumbents

• Omada Health: Omada is a broader digital chronic-care platform with a weight management program serving employers and payors — overlapping with WW's Weight Watchers for Business enterprise channel on the B2B side.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/weightwatchers
• YouTubeyoutube.com/user/WeightWatchers
• Facebookfacebook.com/weightwatchers
• LinkedInlinkedin.com/company/7428
• Instagraminstagram.com/weightwatchers

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A5 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WW International